Video Experimental Relacionado
Updated: Aug 9, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Análisis de sistemas de eventos adversos de drogas. El Grupo de Estudio de Prevención de ADE
L L Leape1, D W Bates, D J Cullen
1Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA.
JAMA
|July 5, 1995
Resumen
Las fallas del sistema en la difusión del conocimiento sobre drogas y el acceso a la información del paciente causan la mayoría de los eventos adversos de drogas (EAD). La mejora de estos sistemas puede reducir los errores de medicación y mejorar la seguridad del paciente.
Área de la Ciencia:
- Calidad y seguridad de la atención sanitaria.
- Análisis del error de medicación Análisis del error de medicación
- Sistemas de salud investigación de los sistemas de salud.
Sus antecedentes:
- Los eventos adversos del fármaco (EAD) y los posibles EAD representan una preocupación significativa para la seguridad del paciente.
- Comprender las causas profundas de estos eventos es crucial para desarrollar estrategias efectivas de prevención.
Objetivo del estudio:
- Identificar y evaluar las fallas de los sistemas que subyacen a los errores que conducen a eventos adversos de drogas (EAD) y posibles EAD.
- Para identificar las debilidades sistémicas comunes en los procesos de uso de drogas en los hospitales.
Principales métodos:
- Un estudio de cohorte prospectivo que involucra el análisis de sistemas de eventos en 11 unidades médicas y quirúrgicas en dos hospitales de atención terciaria durante seis meses.
- Los errores fueron detectados a través de entrevistas y clasificados por causa proximal y fallas de sistemas subyacentes por equipos multidisciplinarios.
Principales resultados:
- Se identificaron 334 errores que causaron 264 EAD prevenibles y EAD potenciales.
- Se encontraron dieciséis fallas importantes en los sistemas, siendo las más comunes la difusión de conocimientos sobre medicamentos (29%) y la disponibilidad de información para pacientes (18%).
- Siete fallas de sistemas representaron el 78% de los errores, lo que pone de relieve el impacto potencial de los sistemas de información mejorados.
Conclusiones:
- El personal del hospital participó activamente en la identificación de fallas de los sistemas relacionados con errores de uso de drogas.
- Las deficiencias en los sistemas para la difusión del conocimiento sobre drogas y el acceso a la información del paciente fueron los principales contribuyentes a los errores.
- La mejora de los sistemas de datos de medicamentos y pacientes es esencial para reducir los errores de medicación y mejorar la seguridad del paciente.
Videos de Conceptos Relacionados
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...